Pulmonary Cytology Guidelines - PSC Companion
Lester Layfield, MD
This course describes the recommendations by the Papanicolaou Society of Cytopathology for categorization of respiratory specimens. The categorization scheme includes diagnostic criteria as well as malignancy risk estimates for each category. Six categories are used: non-diagnostic, negative for malignancy, atypical, neoplastic, suspicious for malignancy, and malignant. The two indeterminate categories of atypical and suspicious are clinically useful because they stratify malignancy risk. The neoplastic category is useful for its ability to deal with non-malignant neoplasms and stratify them into benign and low grade. Molecular testing of non-small cell carcinomas will be briefly addressed.
This educational activity is designed for pathologists, cytopathologists, cytotechnologists, students and other members of the cytopathology community.
- Properly categorize Pulmonory cytology specimens by the P.S.C. recommendations
- Estimate malignancy risk for each diagnostic category
- Define specimen adequacy according to the P.S. C. recommendations
- Understand the distinction between the categories aypical and suspicious for malignancy
Current ACCME guidelines state that participants in CME activities should be made aware of any affiliation or financial interest that may affect the speaker’s presentation(s). Therefore, it is the policy of the ASC to insure balance, independence, objectivity, and scientific rigor in all its educational programs. All planning individuals participating in any ASC Educational Activity are expected to disclose to the program audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program. Click here for a complete list.
Lester Layfield, MD
The presenter has no conflicts of interest or financial relationships to disclose.
ACCREDITATION AND DESIGNATION STATEMENTS
Continuing Medical Education (CME) Statement
The American Society of Cytopathology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The American Society of Cytopathology designates this enduring educational activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
American Board of Pathology Maintenance of Certification (MOC)
This product can help fulfill the CME requirements and Self-Assessment Modules (SAMs) mandated by the American Board of Pathology Maintenance of Certification (MOC) process. Earn up to 2.0 SAM Credit Hours.
Continuing Medical Laboratory Education (CMLE)
The ASC designates this activity for a maximum of 2.0 Continuing Medical Laboratory Education (CMLE) credit hours for non-physicians. The CMLE credit hours meet the continuing education requirements for the ASCP Board of Registry Certification Maintenance Program. Participants should claim only the credit commensurate with the extent of their participation in the activity.
Cytotechnologists with Licenses in Florida and California
This program is approved for 2 continuing education credits in the State of Florida and 1 in the State of California. The credit on each link is good for three years from the live presentation date.
- 2.00 AMA PRA Category 1 Credit™
- 1.00 California Credits
- 2.00 CMLE
- 2.00 Florida Credits
- 2.00 MOC II
- 2.00 Participant